|
 Part
I: General concepts and critical appraisal
Salim Yusuf, Editor
1 What is evidence-based cardiology?
PJ Devereaux, R Brian Haynes, Salim Yusuf
2 A critical appraisal of the cardiovascular history and
physical examination
Akbar Panju, Brenda Hemmelgarn, Jim Nishikawa, Deborah
Cook, Allan Kitching
3 Obtaining incremental information from diagnostic tests
Raymond J Gibbons
4 Clinical trials and meta-analysis
Colin Baigent
5 Finding current best evidence to practice evidence-based
cardiology
Dereck L Hunt, K Ann McKibbon, R Brian Haynes
6 Understanding concepts related to health economics
Mark Hlatky
7 Introduction to decision analysis
Kevin A Schulman, Henry A Glick, Allan S Detsky
8 Assessing and changing cardiovascular clinical practices
C David Naylor, David A Alter
Part II: Prevention of cardiovascular diseases
Salim Yusuf, Editor
9 Global perspective on cardiovascular disease
K Srinath Reddy
10 Tobacco: global burden and community solutions
Terry F Pechacek, Samira Asma, Nicole Blair, Michael P
Eriksen
11 Tobacco and cardiovascular disease: achieving smoking
cessation
Godfrey H Fowler
12 Lipids and cardiovascular disease
Malcolm Law
13 Use of lipid lowering agents in the prevention of cardiovascular
disease
Jeffrey L Probstfield
14 Blood pressure and cardiovascular disease
Curt D Furberg, Bruce M Psaty
15 Glucose abnormalities and cardiovascular disease: "dysglycemia"
as an emerging cardiovascular risk factor
Sarah E Capes, Hertzel C Gerstein
16 Physical activity and exercise in cardiovascular disease
prevention and rehabilitation
Erika S Froelicher, Roberta K Oka, Gerald F Fletcher
17 Psychosocial factors in the primary and secondary prevention
of coronary heart disease: an updated systematic review of
prospective cohort studies
Harry Hemingway, Hannah Kuper, Michael Marmot
18 Emerging approaches in cardiovascular prevention
Eva M Lonn, Marek Smieja, Salim Yusuf
19 Obesity
Arya M Sharma
20 Postmenopausal hormone therapy and cardiovascular disease
Jacques E Rossouw
21 Ethnicity and cardiovascular disease
Sonia S Anand, Stephanie Ounpuu, Salim Yusuf
22 The fetal origins of coronary heart disease
David JP Barker
23 Molecular genetics of cardiovascular disorders
AJ Marian, Robert Roberts
24 Cost effectiveness of prevention of cardiovascular disease
Daniel B Mark
25 Diet and cardiovascular disease
K Srinath Reddy
Part IIIa: Specific cardiovascular disorders: Stable coronary
artery disease
Bernard J Gersh and John A Cairns, Editors
26 Anti-ischemic drugs
Lionel H Opie
27 Impact of revascularization procedures in chronic coronary
artery disease on clinical outcomes: a critical review of
the evidence
Charanjit S Rihal, Dominic Raco, Bernard J Gersh, Salim
Yusuf
28 Adjunctive medical therapy in percutaneous coronary intervention
James L Velianou, Ronald R van der Wieken, Maarten M Simoons
29 Restenosis: etiologies and prevention
Giuseppe Sangiorgi, David R Holmes, Robert S Schwartz
Part IIIb: Specific cardiovascular disorders: Acute ischemic
syndromes and acute myocardial infarction
John A Cairns and Bernard J Gersh, Editors
30 Acute non-ST-segment elevation coronary syndromes: unstable
angina and non-ST-segment elevation myocardial infarction
Pierre Theroux, John A Cairns
31 Fibrinolytic therapy
James S Zebrack, Jeffrey L Anderson
32 Mechanical reperfusion strategies in patients presenting
with acute myocardial infarction
Sanjaya Khanal, W Douglas Weaver
33 Adjunctive antithrombotic therapy for ST-elevation acute
myocardial infarction
John K French, Harvey D White
34 Pain relief, general management, and other adjunctive
treatments
Aldo P Maggioni, Roberto Latini, Gianni Tognoni, Peter
Sleight
35 Complications after myocardial infarction
Peter L Thompson, Barry McKeown
36 An integrated approach to the management of patients after
the early phase of the acute coronary syndromes
Desmond G Julian
Part IIIc: Specific cardiovascular disorders: Atrial fibrillation
and supraventricular tachycardia
A John Camm and John A Cairns, Editors
37 Atrial fibrillation: antiarrhythmic therapy
Harry JGM Crijns, Isabelle C Van Gelder, Irina Savelieva,
A John Camm
38 Atrial fibrillation: antithrombotic therapy
John A Cairns
39 Atrial fibrillation: non-pharmacologic therapies
Sanjeev Saksena, Andrew J Einstein
40 Supraventricular tachycardia: drugs v ablation
Neil R Grubb, Peter Kowey
Part IIId: Specific cardiovascular disorders: Ventricular
arrhythmias, bradyarrhythmias and cardiac arrest
A John Camm, Editor
41 Prevention and treatment of life-threatening ventricular
arrhythmia and sudden death
Eugene Crystal, Stuart J Connolly, Paul Dorian
42 Impact of pacemakers: when and what kind?
William D Toff, A John Camm
43 Syncope
David G Benditt, Cengiz Ermis, Keith G Lurie, Scott Sakaguchi
44 Cardiopulmonary resuscitation
Nicola E Schiebel, Roger D White
Part IIIe: Specific cardiovascular disorders: Left ventricular
dysfunction
Salim Yusuf, Editor
45 Prevention of congestive heart failure and treatment of
asymptomatic left ventricular dysfunction
RS McKelvie, CR Benedict, Salim Yusuf
46 Management of overt heart failure
Bert Andersson, Karl Swedberg
47 Acute myocarditis and dilated cardiomyopathy
Barbara A Pisani, John F Carlquist
48 Hypertrophic cardiomyopathy
Perry M Elliott, Rajesh Thaman, William J McKenna
49 Other cardiomyopathies
José A Marin-Neto, Marcus Vinícius Simões,
Benedito Carlos Maciel
Part IIIf: Specific cardiovascular disorders: Pericardial
disease
Bernard J Gersh, Editor
50 Pericardial disease: an evidence-based approach to diagnosis
and treatment
Bongani M Mayosi, James A Volmink, Patrick J Commerford
Part IIIg: Specific cardiovascular disorders: Valvular
heart disease
Bernard J Gersh, Editor
51 Rheumatic heart disease: prevention and acute treatment
Edmund AW Brice, Patrick J Commerford
52 Mitral valve disease: indications for surgery
Blasé A Carabello
53 Indications for surgery in aortic valve disease
Heidi M Connolly, Shahbudin H Rahimtoola
54 Balloon valvuloplasty: aortic valve
Daniel J Diver, Jeffrey A Breall
55 Balloon valvuloplasty: mitral valve
Zoltan G Turi
56 Valve repair and choice of valves
Paul J Pearson, Hartzell V Schaff
57 Diagnosis and management of infective endocarditis
David T Durack, Michael L Towns
58 Antithrombotic therapy after heart valve replacement
Alexander GG Turpie, Walter Ageno
Part IIIh: Specific cardiovascular disorders: Other conditions
Bernard J Gersh and Salim Yusuf, Editors
59 Treatment of patients with stroke
Craig S Anderson
60 Heart disease and pregnancy
Samuel C Siu, Jack M Colman
61 Venous thromboembolic disease
Clive Kearon, Jeffrey S Ginsberg, Jack Hirsh
62 Peripheral vascular disease
Jesper Swedenborg, Jan Östergren
Part IV: Clinical applications
Ernest L Fallen, Editor
63 Clinical applications of external evidence
Ernest L Fallen, Salim Yusuf
64 Stable angina: choice of PCI v CABG v drugs
Douglas A Holder
65 Acute coronary syndromes
George J Philippides
66 Acute myocardial infarction
Bryan F Dias, Ernest L Fallen
67 Postmyocardial infarction: preventive measures
Ernest L Fallen
68 Metabolic risk and secondary prevention of coronary disease
Jacques Genest Jr
69 Peripheral vascular disease with suspect coronary artery
disease
Peter C Spittell
70 Heart failure
Michael M Givertz
71 Atrial fibrillation
Michael Klein
72 Ventricular dysrhythmias: pharmacologic v non-pharmacologic
treatment
L Brent Mitchell
73 Bradyarrhythmias: choice of pacemaker
John A Boone
74 Valvular heart disease: timing of surgery
Adrian P Banning, Brian B Gribbin
|
